Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MENS
MENS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MENS News
Jyong Biotech Reports Clinical Progress and Market Strategy
3d ago
Yahoo Finance
Jyong Biotech Achieves Milestone with MCS-8 Phase II Trial Success
3d ago
Newsfilter
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
Dec 31 2025
Benzinga
Axsome Therapeutics Plans New Drug Application for AXS-12 in January, Shares Surge 16.1%
Dec 31 2025
Benzinga
Sidus Space Prices Public Offering at $1.30 per Share
Dec 23 2025
Benzinga
U.S. Stocks Rise with Nasdaq Gaining Over 100 Points
Dec 22 2025
Benzinga
Jyong Biotech Experiences Share Price Fluctuation Post Lock-Up Expiry
Dec 19 2025
Globenewswire
Jyong Biotech Experiences Share Price Fluctuation Post Lock-Up Expiry
Dec 19 2025
Newsfilter
Jyong Biotech Stock Reaches Oversold Status (MENS)
Dec 10 2025
NASDAQ.COM
Major Stocks Including Leggett & Platt, New Fortress Energy, and Bausch Health Companies Rise on Monday
Dec 01 2025
Benzinga
Jyong Biotech Signs LOI with Korean Firm to Explore MCS-2 Drug Development
Nov 24 2025
Newsfilter
Jyong Biotech is Currently Oversold (MENS)
Nov 19 2025
NASDAQ.COM
Caterpillar Reports Positive Q3 Earnings, Alongside United Therapeutics, Centene, Fortive, and Other Major Stocks Rising on Wednesday
Oct 29 2025
Benzinga
The 5 Best-Performing Stocks in the Nasdaq Composite for August 2025
Sep 03 2025
NASDAQ.COM
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Jul 01 2025
Benzinga
Show More News
